Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00320125 · ClinicalTrials.gov registry record · Phase 3
Effects of Dairy Foods on Adolescent Pregnant Mothers and Their Newborns
A Phase 3 study of Pregnancy, sponsored by University of Utah.
- Completed
- Registry status
- Phase 3
- Development phase
- 72
- Enrollment target
- 1
- Study location
NCT00320125 is a Phase 3 study of Pregnancy that has completed, run by University of Utah. The registered enrollment target is 72 participants, below the 872-participant average among 191 other Pregnancy trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00320125, a Phase 3 study of Pregnancy, has completed, sponsored by University of Utah.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 72 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of the study is to evaluate the effects of different dietary calcium have on the pregnant teen mother and her newborn. We hypothesize that the higher calcium intake during pregnancy will result in higher bone mass in the newborn.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Orange juice plus calcium
- DIETARY_SUPPLEMENT Dairy products
Study Locations (1)
Utah
- University Hospital - Salt Lake City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 72 participants |
| Start Date | 2002-03 |
| Est. Completion | 2004-06 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00320125
The ClinicalTrials.gov registry entry for NCT00320125 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 72 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 872-participant average among 191 other Pregnancy trials with a reported enrollment target (92% lower). The listed sponsor is University of Utah, which has 818 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Pregnancy appearing as the primary indexed condition, and to 2 interventions - of which Orange juice plus calcium is the first listed.
NCT00320125 reports 1 study location spanning 1 distinct geographic area - top geographies include Utah.
Frequently Asked Questions
What is clinical trial NCT00320125 about?
NCT00320125 is a clinical study titled "Effects of Dairy Foods on Adolescent Pregnant Mothers and Their Newborns". The purpose of the study is to evaluate the effects of different dietary calcium have on the pregnant teen mother and her newborn. We hypothesize that the higher calcium intake during pregnancy will result in higher bone mass in the newborn.
What is the current status of trial NCT00320125?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 72 participants. The study started on 2002-03. Estimated completion is 2004-06.
What conditions does trial NCT00320125 study?
This clinical trial studies the following conditions: Pregnancy.
What interventions are being tested in trial NCT00320125?
The interventions under investigation include: Orange juice plus calcium (DIETARY_SUPPLEMENT), Dairy products (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT00320125?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00320125 being conducted?
This trial has 1 study location across Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pregnancy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Different Medications to Induce Labor
RECRUITING · Phase 3
-
Ropivacaine and Fentanyl for Labor Epidural Initiation
RECRUITING · Phase 3
-
Intravenous Versus Oral Iron for Treating Iron-Deficiency Anemia in Pregnancy
RECRUITING · Phase 3
-
A Phase III Randomized, Double-Blind, Controlled Study of the Use of Anti-HIV Immune Serum Globulin (HIVIG) for the Prevention of Maternal-Fetal HIV Transmission in Pregnant Women and Newborns Receiving Zidovudine (AZT)
COMPLETED · Phase 3
-
The Safety and Effectiveness of Zidovudine in HIV-Infected Pregnant Women and Their Infants
COMPLETED · Phase 3
-
Induction With Misoprostol: Oral Mucosa Versus Vaginal Epithelium (IMPROVE)
COMPLETED · Phase 3
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.